Theranos Investor Conference Presentation Deck

Immunochemistry: HSV-2 IgG Measurements are Consistent with Comparator Method Negative percent agreement (specificity) Positive percent agreement (sensitivity) Theranos/ Immunoblot 127 / 127 71/75 Other industry standard assays approved by FDA: K120625, K090409, K081687 This technology has not been cleared or approved by the FDA and is not for sale in the United States. Percent Agreement 100% 94.7% 95% Confidence Interval (97.1%, 100%) (87.1%, 97.9%) theranos 36

View entire presentation